Lynn Dustin

• Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.

  Journal article

  Laidlaw SM. et al, (2017), Gastroenterology, 153, 566 - 578.e5

• Innate and Adaptive Immune Responses in Chronic HCV Infection.

  Journal article

  Dustin LB., (2017), Current drug targets, 18, 826 - 843

• Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.

  Journal article

  Dustin LB. et al, (2016), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 22, 826 - 832

• MAIT cells are activated during human viral infections.

  Journal article

  van Wilgenburg B. et al, (2016), Nature communications, 7

• Editorial: Recent Advances in HBV and HCV Immunology.

  Journal article

  Dustin LB. and Trehanpati N., (2015), Frontiers in immunology, 6

• Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.

  Journal article

  Zignego AL. et al, (2014), Genes and immunity, 15, 500 - 505

• Immune control and failure in HCV infection--tipping the balance.

  Journal article

  Dustin LB. et al, (2014), Journal of leukocyte biology, 96, 535 - 548

• CHARACTERIZATION OF PHENOTYPE AND IMMUNOGLOBULIN GENES OF AUTOREACTIVE B CELLS IN SJOGREN'S SYNDROME

  Conference paper

  Efthimiou P. et al, (2014), ANNALS OF THE RHEUMATIC DISEASES, 73, 358 - 358

• Immune control of HCV infection

  Chapter

  Dustin LB., (2014), HCV Infection and Cryoglobulinemia, 21 - 36

• The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.

  Journal article

  Cashman SB. et al, (2014), Frontiers in immunology, 5

• Genome-wide association study of hepatitis C virus-and cryoglobulin-related vasculitis

  Journal article

  Zignego AL. et al, (2014), Genes and Immunity, 15, 500 - 505

• Selection of apoptotic cell specific human antibodies from adult bone marrow.

  Journal article

  Grönwall C. et al, (2014), PloS one, 9

• Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.

  Journal article

  Laidlaw SM. and Dustin LB., (2014), Frontiers in immunology, 5

• Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).

  Journal article

  Fuller MJ. et al, (2013), Proceedings of the National Academy of Sciences of the United States of America, 110, 15001 - 15006

• Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.

  Journal article

  Charles ED. et al, (2013), Arthritis and rheumatism, 65, 2430 - 2440

• Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.

  Journal article

  Saeed M. et al, (2012), Antimicrobial agents and chemotherapy, 56, 5365 - 5373

• Too low to measure, infectious nonetheless.

  Journal article

  Dustin LB., (2012), Blood, 119, 6181 - 6182

• Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

  Journal article

  Stegmann KA. et al, (2012), The Journal of infectious diseases, 205, 1351 - 1362

• Natural history, pathogenesis, and prevention of HCV infection

  Chapter

  Charles ED. et al, (2012), HCV Infection and Cryoglobulinemia, 9788847017054, 11 - 19

• Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.

  Journal article

  Dustin LB. and Charles ED., (2012), Antiviral therapy, 17, 1449 - 1452

• Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells.

  Journal article

  Andrus L. et al, (2011), Hepatology (Baltimore, Md.), 54, 1901 - 1912

• Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.

  Journal article

  Marukian S. et al, (2011), Hepatology (Baltimore, Md.), 54, 1913 - 1923

• HCV and Blood Cells: How Can We Distinguish Infection from Association?

  Chapter

  Dustin LB. and Rice CM., (2011), HCV Infection and Cryoglobulinemia, 55 - 62

• Response: proliferative versus functional anergy

  Journal article

  Charles ED. and Dustin LB., (2011), Blood, 118, 3442 - 3442

• Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

  Journal article

  Charles ED. et al, (2011), Blood, 117, 5425 - 5437

• A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells.

  Journal article

  Charles ED. et al, (2011), Journal of immunological methods, 363, 210 - 220

• Chemokine antagonism in chronic hepatitis C virus infection.

  Journal article

  Charles ED. and Dustin LB., (2011), The Journal of clinical investigation, 121, 25 - 27

• Hepatitis C virus-induced cryoglobulinemia.

  Journal article

  Charles ED. and Dustin LB., (2009), Kidney international, 76, 818 - 824

• Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

  Journal article

  Marukian S. et al, (2008), Hepatology (Baltimore, Md.), 48, 1843 - 1850

• Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.

  Journal article

  Charles ED. et al, (2008), Blood, 111, 1344 - 1356

• Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.

  Journal article

  Lake-Bakaar G. et al, (2007), Blood, 109, 845 - 846

• Flying under the radar: the immunobiology of hepatitis C.

  Journal article

  Dustin LB. and Rice CM., (2007), Annual review of immunology, 25, 71 - 99

• Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.

  Journal article

  Romero AI. et al, (2006), The Journal of infectious diseases, 194, 895 - 903

• Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.

  Journal article

  Butera D. et al, (2005), Blood, 106, 1175 - 1182

• Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.

  Journal article

  Chambers TJ. et al, (2005), Journal of virology, 79, 3071 - 3083

• Reexamining the role of the humoral immune response in control of hepatitis C virus infection.

  Journal article

  Dustin LB., (2004), Hepatology (Baltimore, Md.), 40, 756 - 758

• Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

  Journal article

  McKeating JA. et al, (2004), Journal of virology, 78, 8496 - 8505

• Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.

  Journal article

  Ni J. et al, (2003), Journal of immunology (Baltimore, Md. : 1950), 170, 3429 - 3439

• The immunological relay race: B cells take antigen by synapse.

  Journal article

  Dustin ML. and Dustin LB., (2001), Nature immunology, 2, 480 - 482

• Ratiometric analysis of calcium mobilization

  Journal article

  Dustin LB., (2000), Clinical and Applied Immunology Reviews, 1, 5 - 15

• Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.

  Journal article

  Dustin LB. et al, (1999), Journal of immunology (Baltimore, Md. : 1950), 162, 2717 - 2724

• T-B cell interaction inhibits spontaneous apoptosis of mature lymphocytes in Bcl-2-deficient mice.

  Journal article

  Nakayama K. et al, (1995), The Journal of experimental medicine, 182, 1101 - 1109

• Ly-6C is a marker of memory CD8+ T cells.

  Journal article

  Walunas TL. et al, (1995), Journal of immunology (Baltimore, Md. : 1950), 155, 1873 - 1883

• Antigen-driven differentiation of naive Ig-transgenic B cells in vitro.

  Journal article

  Dustin LB. et al, (1995), Journal of immunology (Baltimore, Md. : 1950), 154, 4936 - 4949

• Distinct requirements of positive and negative selection for selecting cell type and CD8 interaction.

  Journal article

  Schönrich G. et al, (1993), Journal of immunology (Baltimore, Md. : 1950), 151, 4098 - 4105

• Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function.

  Journal article

  Dustin LB. et al, (1990), Journal of immunology (Baltimore, Md. : 1950), 144, 4888 - 4897

• Pregnancy as a natural model of allograft tolerance. Interactions between adherent macrophages and trophoblast populations.

  Journal article

  Lu CY. et al, (1989), Transplantation, 48, 848 - 855

• Regulation of macrophage functions in the murine placenta and decidua: Implications for tolerance of the fetal allograft

  Journal article

  Lu CY. et al, (1989), Transplantation Reviews, 3, 195 - 214

• High strength binding of P815 mastocytoma cells is not necessary for their lysis by macrophages which have been primed and triggered in vitro.

  Journal article

  Lu CY. et al, (1988), Journal of immunology (Baltimore, Md. : 1950), 141, 1083 - 1090

• Resolution of the phosphotransferase enzymes of Streptococcus mutans: purification and preliminary characterization of a heat-stable phosphocarrier protein.

  Journal article

  Mimura CS. et al, (1984), Infection and immunity, 44, 708 - 715

Recent Publications

• Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.

  Journal article

  Laidlaw SM. et al, (2017), Gastroenterology, 153, 566 - 578.e5

• Innate and Adaptive Immune Responses in Chronic HCV Infection.

  Journal article

  Dustin LB., (2017), Current drug targets, 18, 826 - 843

• Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.

  Journal article

  Dustin LB. et al, (2016), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 22, 826 - 832

• MAIT cells are activated during human viral infections.

  Journal article

  van Wilgenburg B. et al, (2016), Nature communications, 7

• Editorial: Recent Advances in HBV and HCV Immunology.

  Journal article

  Dustin LB. and Trehanpati N., (2015), Frontiers in immunology, 6